For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.* 

2021-4: How to Accurately Assess Tobacco Use Disorder (TUD)

This presentation will review how to accurately assess TUD in patients with a diagnosis of SUD and introduce implementing a standardized TUD assessment tool.

Presenter:  Carol Essenmacher, DNP, RN, PMHCNS-BC, NCTTP

Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off label use of medications will not be discussed during this presentation.

Session Length:  32 minutes

Target Audience:  RN, APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

• Demonstrate use of a detailed tobacco use assessment to effectively treat TUD in patients diagnosed with a SUD. 
  

Keywords:  Substance Use Disorder, Tobacco Use Disorder

Price: Free

Nursing Continuing Professional Development:
0.5 contact hours.  * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, honor statement, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the posttest and a score of 80% is required to pass. Once you have passed and completed the evaluation and honor statement, your nursing continuing professional development certificate will be generated online and available for immediate printing. Credit cannot be earned unless all components of the program are completed. 

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Release date: December 3, 2021

The contact hours for this session expire: January 31, 2023

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.* 

2021-3: A Primer on Stimulant Use Disorder: A Growing Concern

This presentation will explore stimulant use disorders in the adult population. The neuroscience changes as a result of a SUD will be explored along with the signs and symptoms that often present with the diagnosis and potential treatment options.

Presenter: Laura G Leahy, DrNP, APRN, PMH-CNS/FNP, CARN-AP, FAANP, FAAN

Disclosures: The presenter has indicated a financial interest or other affiliation with Alkermes (Vivitrol), Otsuka (Rexulti) and American Psychiatric Publishing, Inc. Off-label use of medications will be discussed during this presentation. Off label use or investigational use in the presentation include Anticonvulsants, antihypertensives and antidepressants as treatment options for substance use disorders. The activity planners have no conflicts of interest to disclose.

Session Length:  46 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Discuss the prevalence and risks of stimulant use disorder.
• Discuss the neuroscience of stimulant use disorder.
• Discuss the neuroscience of stimulant use disorder.
• Identify potential treatments for stimulant use disorder.
  

Keywords: Stimulant Use Disorder, Substance Use Disorder, Opioid Use Disorder

Price: Free

Nursing Continuing Professional Development:
0.75 contact hours.  * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, honor statement, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the posttest and a score of 80% is required to pass. Once you have passed and completed the evaluation and honor statement, your nursing continuing professional development certificate will be generated online and available for immediate printing. Credit cannot be earned unless all components of the program are completed. 

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Funding for this initiative was made possible (in part) by grant no.1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Release date: December 1, 2021

The contact hours for this session expire: January 31, 2023

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.* 

2021-1: What’s in Grandma’s Medicine Cabinet? – Understanding Substance Use Disorders in Older Adults

This presentation will explore substance use disorders in the older adult population, and how unique age-related physiological and social changes present unique challenges for the identification and treatment of this disorder. 

Presenter:  Kathleen Schachman, PhD, PMHNP-BC, FAANP, FIAAN

Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off label use of medications will not be discussed during this presentation.

Session Length:  45 minutes

Target Audience:  RN, APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

• Estimate the prevalence of substance use/misuse in older adults.
  
• Understand risk factors that may influence this population’s use/misuse of substances.
• Understand physiological differences with aging.
• List three potential treatment approaches that are safe, effective, and tailored to the unique strengths and needs of the older adult who has a substance use disorder (SUD).

Keywords:  Substance Use Disorder, Opioid Use Disorder, Older Adults

Price: Free

Nursing Continuing Professional Development:
0.75 contact hours.  * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, honor statement, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the posttest and a score of 80% is required to pass. Once you have passed and completed the evaluation and honor statement, your nursing continuing professional development certificate will be generated online and available for immediate printing. Credit cannot be earned unless all components of the program are completed. 

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Funding for this initiative was made possible (in part) by grant no.1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Release date: December 1, 2021

The contact hours for this session expire: January 31, 2023

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.* 

2021-2: Substance-Exposed Pregnancies: What to Know As They Grow

This presentation will explore how substance use during pregnancy impacts the maternal/fetal development and increases the neurological vulnerabilities of the neonate.  The unique challenges and opportunities of providing care to a substance-exposed pregnancy will be explored.  The importance of screening procedures will be discussed and how the information obtained during the screening influences the treatment plan.

Presenter: Kathleen Schachman, PhD, PMHNP-BC, FAANP, FIAAN

Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off label use of medications may be discussed during this presentation.

Session Length:  47 minutes

Target Audience:  RN, APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to: 

• Describe two ways that substance use during pregnancy impacts maternal/fetal developmental and neurological vulnerabilities of the neonate.
• Identify the unique challenges and opportunities in providing care for substance-exposed pregnancies.
• Implement screening procedures identify high-risk or problematic substance use during pregnancy.
• Plan treatment approaches to optimize maternal and neonatal outcomes.

Keywords:  Substance Use Disorder, Opioid Use Disorder, Pregnancy, Women’s Health

Price: Free

Nursing Continuing Professional Development:
0.75 contact hours.  * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, honor statement, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the posttest and a score of 80% is required to pass. Once you have passed and completed the evaluation and honor statement, your nursing continuing professional development certificate will be generated online and available for immediate printing. Credit cannot be earned unless all components of the program are completed. 

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Release date: December 1, 2021

The contact hours for this session expire: January 31, 2023

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.* 

2021-6: Opioid Use Disorder Treatment

This presentation will explore treatment options for persons with an opioid use disorder diagnosis and the challenges for the identification and treatment of this disorder. 

Presenter: Susan Dawson, EdD, PMHNP-BC
 

Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  While the use of FDA-approved medications (both generic and brand name) will be discussed, this is not an endorsement or recommendation for any commercial product. Off label use of medications will not be discussed during this presentation.

Session Length:  45 minutes

Target Audience:  RN, APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

• Identify the opioid addiction assessment process and treatment options to utilize with persons who have an opioid use disorder diagnosis.
  
• Provide a focused update on successful opioid use disorder treatment protocols.
  
• Discuss methods that help clients with an opioid use disorder diagnosis adhere to treatment protocols. 
  

Keywords:  Substance Use Disorder, Opioid Use Disorder, Psychopharmacology

Price:  Free

Nursing Continuing Professional Development:
0.75 psychopharmacology contact hours.  * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, honor statement, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the posttest and a score of 80% is required to pass. Once you have passed and completed the evaluation and honor statement, your nursing continuing professional development certificate will be generated online and available for immediate printing. Credit cannot be earned unless all components of the program are completed. 

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Release date: December 9, 2021

The contact hours for this session expire: January 31, 2023

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.* 

2021-5: Maximizing Pharmacological Interventions for Treating Tobacco Use Disorders (TUD); Focus on Nicotine Replacement Therapy (NRT)

This presentation will discuss the use of pharmacotherapies, specifically Nicotine Replacement Therapy (NRT), to assist a person with a diagnosis of Substance Use Disorder to quit tobacco use. The dosage of nicotine in different products will be discussed. 

Presenter: Carol Essenmacher, DNP, RN, PMHCNS-BC, NCTTP

Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off label use of medications will not be discussed during this presentation.

Session Length:  25 minutes

Target Audience:  RN, APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

• Demonstrate application of evidence on effective use of pharmacotherapies for TUD, focusing on clinical practice strategies using NRT to effectively treat TUD for patients living with SUD.

Keywords:  Substance Use Disorder, Tobacco Use Disorder, Psychopharmacology

Price:  Free

Nursing Continuing Professional Development:
0.5 psychopharmacology contact hours.  * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, honor statement, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the posttest and a score of 80% is required to pass. Once you have passed and completed the evaluation and honor statement, your nursing continuing professional development certificate will be generated online and available for immediate printing. Credit cannot be earned unless all components of the program are completed. 

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Funding for this initiative was made possible (in part) by grant no.1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Release date:  December 8, 2021

The contact hours for this session expire:  January 31, 2023

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

1302-21:  The Design of Outpatient Detoxification

This presentation introduces a pragmatic biopsychosocial model for outpatient detoxification. The interactive discussion will provide a step-by-step process of evidence-based detoxification, including the FDA-approved drugs and cutting-edge treatment for substance/alcohol treatment. The participants will leave with a comprehensive understanding of an algorithm for outpatient detoxification.

Presenters:  David N. Ampong, DNP, APRN, PMHNP-BC; Michele Burdette-Taylor, PhD, MSN, RN, NPD-BC

Disclosures:  The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will not be discussed during this presentation.

Session Length:  1 hour 7 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Discuss the criteria for detoxification and the algorithm for detoxification. 

Keywords:  Detoxification, Outpatient, Opioid Withdrawal

Nursing Continuing Professional Development:
1.0 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Originally Presented
APNA 35th Annual Conference

The contact hours for this session expire:  November 30, 2024

4207-21: Implementing the Edinburgh Postnatal Depression Scale (EPDS) and Mini International Psychiatric Interview (MINI) in Each Trimester of Pregnancy to Improve Screening and Treatment of Perinatal Mood and Anxiety Disorders (PMADs)

This presentation discusses current research examining the feasibility and acceptability of implementing the Edinburgh Postnatal Depression Scale (EPDS) throughout pregnancy and the possibility of using the EPDS to identify other mental health diagnoses. A thorough review of perinatal mood and anxiety disorders (PMADS) and current practice will also be examined.

Presenters:  Aparna Kumar, PhD, CRNP; Angela Gerolamo, PhD, CRNP

Disclosures:  The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will not be discussed during this presentation.

Session Length:  21 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Discuss appropriate screening recommendations for perinatal mental health, and implementation of the EPDS and MINI in the clinical setting.

Keywords:  Perinatal Mental Health, Screening, Quality Improvement

Nursing Continuing Professional Development:
0.25 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Originally Presented
APNA 35th Annual Conference

The contact hours for this session expire:  November 30, 2024

4209-21: An Unshakable Commitment to Mental Health: Treating an Epidemic During the 2020 Pandemic

In 2020, behavioral health leaders faced the unparalleled challenges of the COVID-19 pandemic while managing the epidemic of suicides and drug overdoses. COVID-19 presented challenges that required quick expansion of infection prevention protocols and education of staff while maintaining a therapeutic environment. This presentation will review a organization's successful response.

Presenters:  Michelle Spurlock, MSN, MBA; Anne Kelly, EdD, BSN; Pam Long, MSN, MBA

Disclosures:  The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will not be discussed during this presentation.

Session Length:  43 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Discuss strategies to implement infection prevention standards within diverse settings in order to provide safe care and active treatment.

Keywords:  Infection Prevention, Pandemic, Therapeutic Environment, COVID-19

Nursing Continuing Professional Development:
0.75 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Originally Presented
APNA 35th Annual Conference

The contact hours for this session expire:  November 30, 2024

4110-21: COVID-19 Pandemic: Providing Safe Patient Care During an Uncertain and Changing Landscape

This review of the COVID-19 practice change process will engage the audience in strategizing safe clinical psychiatric care as we look beyond COVID-19.  By looking back at the resilience of nursing during the pandemic and the nimbleness needed to make necessary change, nurses will discuss strategies for future integrative care.

Presenters:  Sophie Forte, MS, CNP, ANP-BC; Paula Bolton, MS, CNP, ANP-BC

Disclosures:  The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will not be discussed during this presentation.

Session Length:  53 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Discuss the impact of COVID-19 on psychiatric-mental health care and lessons learned.

Keywords:  Infection Control in Psychiatric Setting, COVID-19, Pandemic, Risk Mitigation

Nursing Continuing Professional Development:
0.75 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Originally Presented
APNA 35th Annual Conference

The contact hours for this session expire:  November 30, 2024